A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis
Conditions: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone furoate as a nasal spray Sponsors: Zheng Liu ENT; Zhejiang Xianju Pharma Tech. Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Hay Fever | Mometasone | Nasonex | Pharmaceuticals | Research | Study